Evidence map›Paper›PMID 30718918›Full record

ArticleOncogene2019

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.

M H Kang, K J Jeong, W Y Kim, H J Lee, G Gong, N Suh, B Győrffy, S Kim, S Y Jeong, G B Mills and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

M H KangDepartment of Convergence Medicine, Ulsan College of Medicine, Seoul, South Korea.
K J JeongDepartment of Systems Biology, MD Anderson Cancer Center, Houston, TX, USA.
W Y KimDepartment of Surgery, Korea University, Guro Hospital, Seoul, South Korea.
H J LeeDepartment of Pathology, ASAN Medical Center, Seoul, South Korea.
G GongDepartment of Pathology, ASAN Medical Center, Seoul, South Korea.
N SuhDepartment of Medicine Engineering, College of Medical Sciences, Soon Chun Hyang University, Asan-si, South Korea.
B GyőrffyMTA TTK Lendület Cancer Biomarker Research Group, Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary.
S KimAnging Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
S Y JeongDepartment of Convergence Medicine, Ulsan College of Medicine, Seoul, South Korea.
G B MillsDepartment of Systems Biology, MD Anderson Cancer Center, Houston, TX, USA.
Y-Y ParkDepartment of Convergence Medicine, Ulsan College of Medicine, Seoul, South Korea. yypark@amc.seoul.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article contained error in Figure 2e. In Figure 2e, the 6

Identifiers

PMID30718918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.